Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Phase I Trial of Anti‐PSMA Designer CAR‐T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2‐T Cell Pharmacodynamics as a Determinant of Clinical Response

1. Metal nanoparticles as a promising therapeutic approach for prostate cancer diagnosis and therapy: a comprehensive review

   Mohamed J. Saadh, Wajida Ataallah Khidr, Karar H. Alfarttoosi +9

   Шарҳ мақолаNanoparticle-Based Drug DeliveryMedical Oncology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000031

2. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

   Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

   МақолаCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.002768